Fanlong Liu
Overview
Explore the profile of Fanlong Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
731
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zhu D, Xia J, Gu Y, Lin J, Ding K, Zhou B, et al.
Ann Surg
. 2020 Nov;
273(6):1066-1075.
PMID: 33214446
Objective: To evaluate the effects of the addition of preoperative hepatic and regional arterial chemotherapy (PHRAC) on prognosis of stage II and III colorectal cancer (CRC) in a multicenter setting....
12.
Guo Y, Zhang Z, Xu X, Xu Z, Wang S, Huang D, et al.
Stem Cells Dev
. 2019 Apr;
28(13):882-896.
PMID: 30991894
Oncolytic adenoviruses (Ads) have potential applications in cancer therapy due to their ability to replicate and induce tumor cell death. However, their clinical application has been limited by the lack...
13.
Jiang W, Yang W, Yuan L, Liu F
Onco Targets Ther
. 2018 Oct;
11:6795-6801.
PMID: 30349312
Background: A kinase-interacting protein 1 (AKIP1) has been reported to play an important role in the development and progression of cancer. However, the clinicopathological and biological roles of AKIP1 in...
14.
Wang W, Liu F, Xiang B, Xiang C, Mou X
Int J Clin Exp Med
. 2016 Jan;
8(10):17102-9.
PMID: 26770303
Glioblastoma (GBM) is the most common and deadliest primary tumor in adults, with current treatments having limited specific and efficient delivery of therapeutic drugs to tumor sites or cells. Therefore,...
15.
Huang D, Lan H, Liu F, Wang S, Chen X, Jin K, et al.
Int J Clin Exp Med
. 2015 Aug;
8(6):8369-76.
PMID: 26309490
Enhancing chemotherapy delivery to tumors, improving tumor growth control, reducing metastasis, and increasing survival are all critical objectives of improved cancer therapy. One of the obstacles to the success of...
16.
Liu F, Ye P, Bi T, Teng L, Xiang C, Wang H, et al.
Hepatogastroenterology
. 2015 Jul;
61(131):652-9.
PMID: 26176052
Background/aims: Increased expression of polymeric immunoglobulin receptor (pIgR) in tumor tissue has been detected in various cancer forms. However, the clinical relevance of pIgR in colon cancer hepatic metastasis remains...
17.
Fang W, Fu C, Chen X, Mou X, Liu F, Qian J, et al.
Oncol Lett
. 2015 Jul;
9(5):2003-2006.
PMID: 26137002
To analyze the single nucleotide polymorphisms (SNPs) of two subtypes of neurokinin (NK) receptors, and (also known as and ), in colorectal cancer (CRC), peripheral blood samples were collected from...
18.
Zhou X, Liu F, Lin C, You Q, Yang J, Chen W, et al.
World J Surg Oncol
. 2015 Jun;
13:199.
PMID: 26055832
Background: This study was designed to compare the long-term surgical outcomes of patients with mid and low rectal cancer after open or hand-assisted laparoscopic surgery (HALS). Methods: A case-matched controlled...
19.
Pan W, Huang S, Zhang J, Zhao B, Wang H, Liu F, et al.
Hepatogastroenterology
. 2014 Apr;
60(128):1927-34.
PMID: 24719929
Background/aims: Heterogeneity in primary tumor and related metastases may result in different response to anticancer therapy. Previous work revealed that there were heterogeneity in primary colon carcinoma and matched lymphatic...
20.
Wang Q, Chen P, Chen D, Liu F, Pan W
J Int Med Res
. 2014 Feb;
42(2):270-81.
PMID: 24496148
Objective: To investigate the association between a single nucleotide polymorphism rs2274223 (adenine [A] to guanine [G]) in the phospholipase C epsilon 1 (PLCE1) gene and susceptibility to colorectal cancer (CRC)....